ACAT NP Life Sciences Health Industry Group Inc.
Fundamentals / CIK 0001781726 / USDNP Life Sciences Health Industry Group Inc. reported $165K in revenue and a net loss of $2.9K for the fiscal year ended December 31, 2023 (up 61.4% year over year), with a -0.4% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ACAT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2023$165K +61.4% YoY
-
Operating Income FY 2023-$690 -0.4% margin
-
Net Income FY 2023-$2.9K -1.8% net margin
-
Diluted EPS FY 2023$0.00 Split-adjusted
-
Free Cash Flow FY 2023-- Operating CF less CapEx
-
Cash & ST Investments Dec 31, 2023$71K Total debt: --
Annual revenue and net income
5 fiscal years (2019 to 2023), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Revenue | $165K | $102K | $35K | $15K | $43K |
| Operating Income | -$690 | -$19K | -$66K | -$131K | -$109K |
| Interest Income | -- | -- | $4 | $26 | $32 |
| Interest Expense | $645 | $1 | -- | -- | -- |
| Income Before Tax | -$1.3K | -$19K | -$66K | -$131K | -$109K |
| Income Tax Expense | $1.6K | -- | -- | -- | -- |
| Net Income | -$2.9K | -$19K | -$66K | -$131K | -$109K |
| Basic EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | 43.0M | 43.0M | 43.0M | 43.0M | 34.1M |
| Diluted Shares Outstanding | 43.0M | 43.0M | 43.0M | 43.0M | 34.1M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10K | $18K | $107K | $30K | -- | $41K | $15K | -- |
| Operating Income | -$36K | -$37K | $71K | $1.2K | $17K | -$5.4K | $1.1K | -$31K |
| Interest Income | -- | -- | -- | -- | -- | -- | $1 | -- |
| Income Before Tax | -$37K | -$37K | -- | $1.2K | $17K | -$5.4K | $1.1K | -$31K |
| Net Income | -$15K | -$38K | $71K | $1.2K | $17K | -$5.4K | $1.1K | -$31K |
| Basic EPS | -- | -- | -- | $0.00 | -- | -- | -- | $0.00 |
| Basic Shares Outstanding | -- | 43.0M | 43.0M | 43.0M | -- | 43.0M | 43.0M | 43.0M |
| Diluted Shares Outstanding | -- | 43.0M | 43.0M | -- | -- | 43.0M | 43.0M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $71K | $122K | $28K | $119K | $243K | $200 |
| Cash & Short-Term Investments | $71K | $122K | $28K | $119K | $243K | $200 |
| Total Current Assets | -- | -- | -- | -- | -- | $200 |
| Intangible Assets | -- | -- | -- | -- | $7.2K | -- |
| Total Non-Current Assets | -- | -- | -- | -- | -- | $0 |
| Total Assets | $77K | $128K | $38K | $119K | $250K | $200 |
| Accounts Payable | $6.1K | $6.1K | -- | -- | $1.0K | $466 |
| Deferred Revenue (Current) | -- | $100K | -- | -- | -- | -- |
| Total Current Liabilities | $38K | $108K | -- | -- | -- | -- |
| Total Non-Current Liabilities | $22K | $0 | -- | -- | -- | -- |
| Total Liabilities | $60K | $108K | $239 | $15K | $15K | $21K |
| Common Stock | $4.3K | $4.3K | $4.3K | $4.3K | $4.4K | $7 |
| Retained Earnings | -$348K | -$345K | -$326K | -$261K | -$130K | -$21K |
| Total Stockholders' Equity | -- | $19K | $38K | $104K | $235K | -$21K |
| Total Equity | $16K | $19K | $38K | $104K | $235K | -$21K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $71K | $85K | $125K | $140K | $122K | $7.0K | $575 | $23K |
| Cash & Short-Term Investments | $71K | $85K | $125K | $140K | $122K | $7.0K | $575 | $23K |
| Total Assets | $77K | $95K | $144K | $142K | $128K | $17K | $17K | $25K |
| Accounts Payable | $6.1K | $6.0K | $6.0K | $6.0K | $6.1K | $9.2K | $3.9K | -- |
| Deferred Revenue (Current) | -- | $10K | $7.5K | $113K | $100K | -- | -- | $15K |
| Total Current Liabilities | $38K | -- | -- | -- | $108K | -- | -- | -- |
| Total Non-Current Liabilities | $22K | -- | -- | -- | $0 | -- | -- | -- |
| Total Liabilities | $60K | $64K | $77K | $122K | $108K | $14K | $8.9K | $18K |
| Common Stock | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K |
| Retained Earnings | -$348K | -$333K | -$298K | -$344K | -$345K | -$362K | -$356K | -$358K |
| Total Stockholders' Equity | -- | $32K | $67K | $21K | $19K | $2.7K | $8.2K | $7.1K |
| Total Equity | $16K | $32K | $67K | $21K | $19K | $2.7K | $8.2K | $7.1K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Net Income | -$2.9K | -$19K | -$66K | -$131K | -$109K |
| Change in Payables | -- | $6.1K | -- | -$1.0K | $565 |
| Operating Cash Flow | -$74K | $94K | -$91K | -$124K | -$4.3K |
| Investing Cash Flow | -- | -- | -- | -- | -$8.6K |
| Common Stock Issued | -- | -- | -- | -- | $364K |
| Financing Cash Flow | $22K | -- | -- | -- | $364K |
| Net Change in Cash | -$51K | $94K | -$91K | -$124K | $243K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$15K | -$38K | $71K | $1.2K | $17K | -$5.4K | $1.1K | -$31K |
| Change in Payables | -- | $0 | $0 | -$105 | -- | -- | -- | -- |
| Operating Cash Flow | -$14K | -$41K | -$37K | $18K | $115K | $6.4K | -$23K | -$4.9K |
| Net Change in Cash | -$14K | -$41K | -$15K | $18K | $115K | $6.4K | -$23K | -$4.9K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Operating Margin | -0.4% | -18.5% | -187.7% | -873.9% | -253.2% |
| Net Profit Margin | -1.8% | -18.5% | -187.7% | -873.8% | -253.1% |
| Return on Equity (ROE) | -- | -97.6% | -172.1% | -126.2% | -46.3% |
| Return on Assets (ROA) | -3.8% | -14.8% | -171.0% | -110.5% | -43.5% |
| Quick Ratio | 1.85x | 1.12x | -- | -- | -- |
| Revenue Growth (YoY) | +61.4% | +191.5% | +133.3% | -65.1% | -- |
| Operating Cash Flow Growth (YoY) | -178.4% | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -0.4% | -- | -- | -- | -- | -- | -- | -- |
| Net Profit Margin | 11.8% | -- | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | 161.8% | 124.5% | 65.5% | -97.6% | -117.2% | -227.7% | -1022.6% |
| Return on Assets (ROA) | 25.2% | 53.9% | 58.0% | 9.4% | -14.8% | -18.8% | -109.1% | -291.9% |
| Quick Ratio | 1.85x | -- | -- | -- | 1.12x | -- | -- | -- |
| Revenue Growth (YoY) | -- | -57.3% | +614.9% | -- | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -316.0% | -- | +6528.8% | -- | -48.6% | -- | -- | -- |
| Net Income Growth (YoY) | -192.5% | -- | +6504.4% | -- | -48.6% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -112.1% | -736.1% | -- | -- | +3761.2% | -- | -- | -- |